Phase II evaluation of oral estramustine and oral etoposide in hormone- refractory adenocarcinoma of the prostate

K. J. Pienta*, B. Redman, M. Hussain, G. Cummings, P. S. Esper, C. Appel, L. E. Flaherty

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

213 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II evaluation of oral estramustine and oral etoposide in hormone- refractory adenocarcinoma of the prostate'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience